Masahiro Kawahara Selected Research

Masahiro Kawahara Research Topics

Disease

17	Alzheimer Disease (Alzheimer's Disease) 04/2020 - 09/2003
16	Neoplasms (Cancer) 12/2022 - 11/2006
13	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2020 - 02/2002
9	Dementia (Dementias) 04/2020 - 11/2005
7	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022 - 08/2017
7	Prion Diseases (Transmissible Spongiform Encephalopathies) 03/2020 - 05/2009
6	Colitis 01/2022 - 01/2017
6	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 07/2021 - 08/2015
5	Inflammation (Inflammations) 01/2021 - 01/2017
4	Pulmonary Fibrosis (Fibrosing Alveolitis) 02/2022 - 01/2017
4	Idiopathic Pulmonary Fibrosis 02/2022 - 01/2017
4	Lung Injury 01/2022 - 01/2017
4	Leukemia 01/2020 - 11/2006
4	AIDS-Related Complex (ARC) 08/2015 - 10/2007
3	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 01/2018
3	Fibrosis (Cirrhosis) 01/2022 - 01/2017
3	Ulcerative Colitis 01/2022 - 04/2020
3	Ischemia 07/2021 - 06/2007
3	Infections 01/2021 - 02/2004
3	Prostatic Neoplasms (Prostate Cancer) 03/2020 - 01/2016
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020 - 10/2009
3	Body Weight (Weight, Body) 01/2019 - 01/2017
3	Brain Diseases (Brain Disorder) 07/2016 - 11/2005
3	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 07/2016 - 11/2005
3	Parkinsonian Disorders (Parkinsonism) 07/2016 - 11/2005
3	Carcinogenesis 09/2014 - 07/2009
3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 06/2014 - 10/2009
2	Necrosis 05/2022 - 01/2022
2	Crohn Disease (Crohn's Disease) 01/2022 - 04/2020
2	Neoplasm Metastasis (Metastasis) 09/2021 - 07/2009
2	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2021 - 01/2019
2	Acute Lung Injury 01/2021 - 01/2020
2	Hemorrhage 12/2020 - 05/2020
2	Pulmonary Emphysema 01/2019 - 01/2018
2	Hematologic Neoplasms (Hematological Malignancy) 07/2007 - 11/2006
2	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 07/2007 - 11/2006
1	Cancer Pain 01/2022
1	Emphysema 01/2022
1	Mood Disorders (Mood Disorder) 01/2022

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2006
10	CarnosineIBA 04/2020 - 06/2007
9	ZincIBA 07/2021 - 02/2002
8	Pharmaceutical PreparationsIBA 12/2022 - 06/2007
7	MetalsIBA 04/2020 - 11/2005
5	Prion ProteinsIBA 01/2021 - 04/2011
5	Amyloid (Amyloid Fibrils)IBA 03/2020 - 05/2009
4	CollagenIBA 02/2022 - 01/2017
4	Therapeutic UsesIBA 02/2022 - 01/2017
4	Histidine (L-Histidine)FDA Link 04/2020 - 06/2007
4	AluminumIBA 07/2016 - 09/2003
3	Bleomycin (Blenoxane)FDA LinkGeneric 02/2022 - 01/2017
3	Pancreatic Elastase (Elastase)IBA 01/2022 - 01/2018
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 02/2017
3	Dextran SulfateIBA 01/2022 - 11/2018
3	AntioxidantsIBA 01/2022 - 01/2019
3	CopperIBA 07/2021 - 01/2017
3	Dextrans (Dextran)FDA Link 03/2021 - 01/2019
3	SodiumIBA 04/2020 - 02/2017
3	Amyloidogenic ProteinsIBA 03/2020 - 04/2011
3	Trace Elements (Biometals)IBA 01/2014 - 05/2013
3	CalciumIBA 11/2013 - 05/2004
3	Phosphotransferases (Kinase)IBA 10/2013 - 10/2007
3	AntigensIBA 06/2013 - 11/2006
3	Amyloid beta-PeptidesIBA 05/2009 - 05/2004
2	AntibodiesIBA 05/2022 - 01/2019
2	lecithinized superoxide dismutaseIBA 01/2022 - 02/2017
2	Messenger RNA (mRNA)IBA 01/2022 - 10/2007
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 09/2014
2	MetallothioneinIBA 01/2022 - 11/2013
2	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 10/2021 - 01/2020
2	2-mercaptopurineIBA 10/2021 - 01/2020
2	sodium sulfate (sodium bisulfate)FDA LinkGeneric 03/2021 - 04/2020
2	SynucleinsIBA 03/2020 - 04/2011
2	LipopolysaccharidesIBA 01/2020 - 01/2017
2	polaprezinc (Z 103)IBA 01/2019 - 01/2018
2	Single-Chain AntibodiesIBA 01/2019 - 02/2004
2	InterleukinsIBA 08/2017 - 08/2008
2	Biological ProductsIBA 01/2012 - 11/2010
2	tyrosine receptor (receptor, tyrosine)IBA 07/2009 - 10/2007
2	Peptides (Polypeptides)IBA 07/2007 - 11/2006
1	Chimeric Antigen ReceptorsIBA 05/2022
1	pirfenidoneIBA 02/2022
1	eperisoneIBA 02/2022
1	nintedanibIBA 02/2022
1	SmokeIBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	Lipocalin-2IBA 01/2022
1	IntegrinsIBA 01/2022
1	Urea (Carbamide)FDA LinkGeneric 01/2022
1	Volatile Oils (Essential Oils)IBA 01/2022
1	vedolizumabIBA 01/2022

Therapy/Procedure

8	Therapeutics 05/2022 - 06/2013
5	Radiotherapy 11/2021 - 01/2012
4	Immunotherapy 04/2009 - 11/2006
2	Chemoradiotherapy 08/2021 - 05/2020
2	Drug Therapy (Chemotherapy) 05/2020 - 11/2008
2	Heavy Ion Radiotherapy 03/2020 - 01/2016
2	Oral Administration 01/2019 - 01/2017
1	Aromatherapy 01/2022
1	Complementary Therapies (Alternative Medicine) 01/2022